Sign Up for a Free Account

Evidence-based medicine measures from trials of mitoxantrone, glatiramer acetate, or natalizumab in relapsing-remitting multiple sclerosis

Evidence-based medicine measures calculated from the published trials of mitoxantrone, glatiramer acetate, or natalizumab in relapsing-remitting multiple sclerosis. (Contributed by Dr. Luca Durelli.)

Related Media